121 related articles for article (PubMed ID: 29750706)
1. Immunohistochemical Analysis of Somatostatin Receptors in Endometriosis Tissue Samples: A Retrospective Study.
Fastrez M; Marchisello C; Rassy M; Rozenberg S; Sirtaine N
Int J Gynecol Pathol; 2019 Jul; 38(4):371-376. PubMed ID: 29750706
[TBL] [Abstract][Full Text] [Related]
2. Histological and Immunohistochemical Characterization of the Similarity and Difference Between Ovarian Endometriomas and Deep Infiltrating Endometriosis.
Liu X; Zhang Q; Guo SW
Reprod Sci; 2018 Mar; 25(3):329-340. PubMed ID: 28718381
[TBL] [Abstract][Full Text] [Related]
3. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC
Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225
[TBL] [Abstract][Full Text] [Related]
4. Pathogenetic Mechanisms of Deep Infiltrating Endometriosis.
Tosti C; Pinzauti S; Santulli P; Chapron C; Petraglia F
Reprod Sci; 2015 Sep; 22(9):1053-9. PubMed ID: 26169038
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with deep infiltrating endometriosis versus ovarian endometrioma in China: a subgroup analysis from the FEELING study.
Dai Y; Zhou Y; Zhang X; Xue M; Sun P; Leng J; Chapron C
BMC Womens Health; 2018 Dec; 18(1):205. PubMed ID: 30577792
[TBL] [Abstract][Full Text] [Related]
6. Urocortin and corticotrophin-releasing hormone receptor type 2 mRNA are highly expressed in deep infiltrating endometriotic lesions.
Carrarelli P; Luddi A; Funghi L; Arcuri F; Batteux F; Dela Cruz C; Tosti C; Reis FM; Chapron C; Petraglia F
Reprod Biomed Online; 2016 Oct; 33(4):476-483. PubMed ID: 27567427
[TBL] [Abstract][Full Text] [Related]
7. Expression of microtubule associated protein 2 and synaptophysin in endometrium: high levels in deep infiltrating endometriosis lesions.
Gori M; Luddi A; Belmonte G; Piomboni P; Tosti C; Funghi L; Zupi E; Lazzeri L; Petraglia F
Fertil Steril; 2016 Feb; 105(2):435-43. PubMed ID: 26604067
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical somatostatin receptor expression in insulinomas.
Peltola E; Vesterinen T; Leijon H; Hannula P; Huhtala H; Mäkinen M; Nieminen L; Pirinen E; Rönty M; Söderström M; Arola J; Jaatinen P
APMIS; 2023 Apr; 131(4):152-160. PubMed ID: 36680557
[TBL] [Abstract][Full Text] [Related]
9. Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.
Singh V; Brendel MD; Zacharias S; Mergler S; Jahr H; Wiedenmann B; Bretzel RG; Plöckinger U; Strowski MZ
J Clin Endocrinol Metab; 2007 Feb; 92(2):673-80. PubMed ID: 17105845
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles separate endometriosis lesion subtypes and indicate a sensitivity of endometrioma to estrogen suppressive treatments through elevated ESR2 expression.
Marla S; Mortlock S; Heinosalo T; Poutanen M; Montgomery GW; McKinnon BD
BMC Med; 2023 Nov; 21(1):460. PubMed ID: 37996888
[TBL] [Abstract][Full Text] [Related]
12. Value of the
Fastrez M; Artigas C; Sirtaine N; Wimana Z; Caillet M; Rozenberg S; Flamen P
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():69-74. PubMed ID: 28342392
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor 1 (SSTR1) and somatostatin receptor 5 (SSTR5)expression in hepatocellular carcinoma.
Koc EU; Ozgur T; Yerci O; Gurel S
Hepatogastroenterology; 2013 Oct; 60(127):1693-7. PubMed ID: 24634938
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.
Schmid HA; Lambertini C; van Vugt HH; Barzaghi-Rinaudo P; Schäfer J; Hillenbrand R; Sailer AW; Kaufmann M; Nuciforo P
Neuroendocrinology; 2012; 95(3):232-47. PubMed ID: 22156600
[TBL] [Abstract][Full Text] [Related]
15. Expression of somatostatin and its receptor 1-5 in endometriotic tissues and cells.
Zhao Y; Peng L; Li X; Zhang Y
Exp Ther Med; 2018 Nov; 16(5):3777-3784. PubMed ID: 30405748
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies.
Lambertini C; Barzaghi-Rinaudo P; D'Amato L; Schulz S; Nuciforo P; Schmid HA
Regul Pept; 2013 Nov; 187():35-41. PubMed ID: 24188818
[TBL] [Abstract][Full Text] [Related]
17. Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: an immunohistochemical analysis.
Kumar U
Neuroscience; 2005; 134(2):525-38. PubMed ID: 15961235
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors.
Vesterinen T; Leijon H; Mustonen H; Remes S; Knuuttila A; Salmenkivi K; Vainio P; Arola J; Haglund C
J Clin Endocrinol Metab; 2019 Jun; 104(6):2083-2093. PubMed ID: 30657933
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor 2 expression in the human endometrium through the menstrual cycle.
Green VL; Richmond I; Maguiness S; Robinson J; Helboe L; Adams IP; Drummond NS; Atkin SL
Clin Endocrinol (Oxf); 2002 May; 56(5):609-14. PubMed ID: 12030911
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and functional relevance of somatostatin receptor-1, -2, and -5 in endometrium and endometriotic lesions.
Fasciani A; Quilici P; Biscaldi E; Flamini M; Fioravanti A; Orlandi P; Oliviero J; Repetti F; Bandelloni R; Danesi R; Simoncini T; Bocci G
J Clin Endocrinol Metab; 2010 Dec; 95(12):5315-9. PubMed ID: 20739383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
